In some studies glycated albumin is suggested as an alternative marker for glycemic control in many diabetes complications, including nephropathy [101], retinopathy [102] and Alzheimer’s disease [72] and also in the case of hemodialysis patients [103] or gestational diabetes [97]. This evidence concerns the gene ALB and retinal disorder.